
Lindsey Roeker, MD
Hematologic Oncologist
Titles
Assistant Attending Physician
Clinical Expertise
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma; Lymphoproliferative Disorders
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Roeker accepts the following list of insurance providers. Select your insurance provider to see more details.
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO, DSN
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO EPO
Payor Type: Commercial
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): Federal Government
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP
Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): TBD
Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO
Payor Type: Commercial
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Contact and Location
- 646-608-4115 Office Phone
- Speaks English

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
See all locationsAbout Me
Education
MD, Mayo Clinic School of Medicine
Residencies
Internal Medicine - Brigham and Women’s Hospital
Fellowships
Hematology and Medical Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
Internal Medicine
I am a hematologist and medical oncologist with expertise in leukemia, including chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), Richter’s transformation, and lymphoproliferative disorders. I am deeply committed to partnering with my patients and their families through every stage of their cancer journey while delivering high-quality, thoughtful care.
As a clinical researcher and member of the MSK CLL program, I develop and lead clinical trials that bring cutting-edge treatments to patients with CLL/SLL and Richter’s transformation. Along with a team of dedicated doctors, nurses, and scientists, I am working to move the field forward with innovative approaches, including novel agents and immunotherapies.
I strive to communicate clearly and honestly as I work with each individual to tailor a treatment plan that honors their priorities. Through this process, I aim to maximize my patients’ emotional and physical health.
I am deeply committed to partnering with my patients and their families through every stage of their cancer journey while delivering high-quality, thoughtful care.
-Dr. Roeker
Awards and Honors
- Research Training Award for Fellows, American Society of Hematology (2019)
- Chief Fellow, Memorial Sloan Kettering Cancer Center (2018-2019)
- John Mendelsohn Housestaff Teaching Award, Memorial Sloan Kettering Cancer Center (2018)
- Resident Mentor Award, Brigham and Women’s Hospital (2017)
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Roeker
- A Phase I Study of PSB202 in People with Recurrent or Persistent Indolent B-Cell Lymphoma
- A Phase II Study of Venetoclax and Obinutuzumab as Initial Therapy for Chronic Lymphocytic Leukemia
- A Phase III Study Assessing Early versus Delayed Treatment with Venetoclax and Obinutuzumab for Newly Diagnosed Patients with High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma without Symptoms
- A Phase III Study of LOXO-305 versus Standard Treatment for Persistent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Read more
- A Phase III Study of Venetoclax and Rituximab with and without Pirtobrutinib for Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- A Study Assessing Minimal Residual Disease to Minimize Side Effects in People with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Were Treated with Venetoclax
- Clinical Trials Co-Investigated by Dr. Roeker
- A Phase I Study of BGB-16673 in People with B Cell Cancers
- A Phase I Study of Epcoritamab in People with Relapsed or Persistent Chronic Lymphocytic Leukemia
- A Phase IB Study of Mosunetuzumab in People with Recurrent or Persistent Chronic Lymphocytic Leukemia
- A Phase III Study of Venetoclax plus Acalabrutinib or Obinutuzumab in People with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Roeker’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Lindsey Roeker discloses the following relationships and financial interests:
-
AbbVie
Provision of Services -
Aptitude Health
Provision of Services -
Asociacion Civil de Investigación y Desarrollo en Salud (ACINDES)
Provision of Services -
Association of Community Cancer Centers
Provision of Services -
AstraZeneca
Provision of Services -
BeiGene, Ltd.
Provision of Services -
Fundacion Espanola de Hematologia y Hemoterapia
Provision of Services -
Janssen Oncology, Inc.
Provision of Services -
Karger Publishers
Provision of Services -
Loxo Oncology
Provision of Services -
MJH Life Sciences
Provision of Services
-
National Health and Medical Research Council (NHMRC)
Provision of Services -
New England Journal of Medicine (NEJM)
Provision of Services -
OncLive
Provision of Services -
Pfizer, Inc.
Provision of Services -
Pharmacyclics
Provision of Services -
Red Med Ed LLC
Provision of Services -
Research to Practice
Provision of Services -
TG Therapeutics, Inc
Provision of Services -
The Lockwood Group LLC
Provision of Services -
Vaniam Group
Provision of Services -
Verastem
Provision of Services (uncompensated)
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].